The global medical nutrition market size is expected to reach the market value of more than US$ 90 billion by 2030, growing at a CAGR of over 8% during the forecast period from 2022 to 2030. Medical Nutrition introduces to therapeutic compositions specially handled or formulated and planned for the dietary management of patients. This nutrition is carefully recommended by medical professionals and is also consumed under medical supervision. Medical nutrition addresses the dietary needs of patients with perpetual diseases, for example, diabetes, cancer, immune system issue, and others. Changing ways of life of patients combined with the emergence of rare diseases have created the demand for medical nutrition. The increasing aging population is presently perceived as a global issue of importance. Changes in way of life have brought about rapid aging amongst the population, increasing the prevalence of various diseases. The total aging population (more than 65 years) recorded substantial development in the past couple of decades - from 9.2% in 1990 to 11.7% in 2013. The number of more established individuals is required to develop from 841 Mn in 2013 to more than 2 Bn in 2050, according to the World Population Report. Furthermore, the geriatric population is more inclined to diseases, for example, anxious scatters, Parkinson's, diabetes, and organ system failure. Such patients experience the ill effects of prohibitive food ingestion and require parenteral medical nutrition encouraging to maintain their nutritional dimensions.
The global medical nutrition market size is expected to reach at nearly USD 2.68 billion in 2026. The global medical nutrition market is likely to expand at a CAGR of more than 6.4% from 2019 to 2026.
Chronic obstructive pulmonary disease (COPD) is one of the major causes of disability. According to the World Health Organization (WHO), COPD is viewed as one of the top causes of deaths for quite a long time and is relied upon to increase. It has been estimated to be in charge of the deaths of 3 Mn patients in 2015, globally. Malnutrition is viewed as one of the common problems in COPD patients who require medical nutrition support for survival. Increasing occurrence of disease-related malnutrition is also expected to drive the global medical nutrition market.
Advances in biotechnology have culminated in the upset of the medical nutrition market as manufacturers are increasingly concentrating on the research and development of better and customized medical nutrition items in the market. Subsequently, the development of disease-explicit specialized medical nutrition items, especially in the created nations is on the ascent.
Parenteral medical nutrition therapy fills in as an important therapeutic modality for the treatment and mitigation of ceaseless disease conditions. The prime reason for the utilization of parenteral medical nutrition is to cover adequate nutrition intake when oral or enteral nourishing isn't adequate to meet the required nutritional necessities of patients. As a rule, because of the more expensive rates of parental medical nutrition, consumers may settle on oral and enteral encouraging for nutrition intake, which is relied upon to frustrate the segmental development of the parenteral medical nutrition market.
The global market is required to develop at a significant rate of development inferable from the high awareness dimensions of patients regarding certain foods and their positive impacts on health. Demand for medical nutrition therapy to increase the survival rate among infants is required to look good for the market in the coming years. The uptick saw in the number of malnourished patients combined with the boom in the geriatric populace is probably going to goad the medical nutrition market demand.
Medical nutrition is the therapeutic nutritional supplements recommended to satisfy the particular nutritional necessities of the patient. It is utilized as a part of the treatment of various diseases and clutters, for example, diabetes, Parkinson's disease, cancer, gastrointestinal turmoil, malnutrition, and immune system issue. Supplements play a vital job in the biochemical procedure of the body. So as to make the body work optimally, nutrition substance ought to be available to the body in adequate quantity, and in the correct form. Supplements comprise vitamins and minerals. Supplements are obtained through the eating regimen and through the procedures inside the body, including the action of the gut bacteria. However, amid stress or diseased condition, these supplements may not be absorbed by the body through a regular eating routine. Medical nutrition helps address these particular needs of the body.
On the basis of indication, the oncology nutrition possesses a considerable share in the medical nutrition market, trailed by nervous system science nutrition. Because of the high prevalence of the cerebrovascular issue, dementia and strokes in neurological disarranges, medical nutrition is prominently consumed by the patients experiencing these diseases.
Amongst the pediatric population, the consumption of medical nutrition is high amongst the infants aged short of what one year. The average length of hospital stay for pediatric patients is relatively not as much as that for the adult and the geriatric population, which attributes for the higher market shares of adult and geriatric end-client segments in the medical nutrition market.
The development in the medical nutrition market is helped by the developing inclination of patients for Home Parenteral and Enteral Nutrition (HPEN), and the reimbursements offered to the patients for medical nutrition. The demand for better quality therapy and healthcare facilities in created nations is also liable to fuel the development of the medical nutrition market.
Parenteral medical nutrition administration demands regular assessment and monitoring so as to avoid complications or reactions. Inappropriate usage of this medical nutrition maximizes the potential danger of adverse occasions, for example, re-encouraging syndrome, particulate contamination, catheter diseases, and liver brokenness for the patients experiencing medical nutrition therapy. Catheter-related bloodstream disease (CRBSI) is a grave complication among patients and requires a visit and costly parenteral medical nutrition therapy. An article distributed by the American Society for Nutrition in 2014 also indicated that long haul parenteral medical nutrition therapy significantly increases the danger of liver disease and metabolic complications in patients.
North America market is the largest region for medical nutrition market globally pursued by Europe. Rising prevalence of malnutrition has pushed the development of medical nutrition market in the North America area. According to the Feeding America 2015, around 2 million individuals experience the ill effects of starvation in the U.S, including 13 million youngsters. The North America market is projected to dominate the global medical nutrition market in 2017. North America is relied upon to gain significant market share in income terms by 2027 end. Moreover, the US has been anticipated to display a significant CAGR amid the forecast time frame, in the medical nutrition market.
The prevalence of IBD and GI tract issue is increasing at a steady rate in the Asia Pacific region, which is relied upon to accelerate the segmental development of the medical nutrition market. The Asia Pacific is relied upon to be the dominant locale for medical nutrition market over the forecast time frame and the factors in charge of an increasing number of diseases, for example, diabetes, cancer, and others. The rapidly developing prevalence of cancers is also expected to majorly add to the development of the global medical nutrition market. On the opposite side, the Middle East and Africa locale are relied upon to enlist relatively low development in the medical nutrition market, as the limited access to astounding care still prevails.
Market Segmentation by Type:
Market Segmentation by Indication:
Market Segmentation by End User:
Market Segmentation by Flavor:
Market Segmentation by Distribution Channel:
Market Segmentation by Region:
The market research study on “Medical Nutrition Market (By Type: Standard Formula, Specialized Formula; By Indication: Diabetes, Dysphagia, General Well-being, Hepatic Disorders, IBD & GI, Neurological Disorders, Oncology Nutrition, Renal Disorders, Respiratory Disorders, Others; By End User: Adult, Geriatric, Pediatric; By Flavor: Regular, Flavored; By Distribution Channel: Direct, Indirect) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global medical nutritionmarket segments with market dynamics and their impact. The report provides insights on global medical nutritionmarket by type, indication, enduser, flavor, distribution channel, and major geographic regions.
Nutrica has launched an innovative NeocateSyneo in 2016, a one of a kind mix of probiotics and prebiotics, which is considered to help the development of balanced gut microbiota in infants experiencing numerous food allergies, milk allergy, and related gastrointestinal conditions. Neocatesyneo is the first hypoallergenic formula launched in the pediatric nutrition business.
Major companies contributing the global medical nutrition market are Abbott Laboratories, AYMES International Ltd., B. Braun Melsungen AG., Baxter International Inc., Cambrooke Therapeutics, Inc., Danone Nutricia, Fresenius Kabi AG, GlaxoSmithKline plc, Kate Farms, Inc., Mead Johnson & Company, LLC, Medifood GmbH, Medtrition Inc., Meiji Holdings Co., Ltd., Nestlé S.A., NUTRICIÓN MÉDICA SL, Otsuka Pharmaceutical Europe Ltd., Perrigo Company plc, Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Victus, Inc.
The global medical nutrition market accounted for more than US$ 75 Billion in 2021
The global medical nutrition market is expected to grow at a CAGR of around 8% during the period from 2022 to 2030
North America medical nutrition market is expected to lead the global market regionally.
Abbott Laboratories, AYMES International Ltd., B. Braun Melsungen AG., Baxter International Inc., Cambrooke Therapeutics, Inc., Danone Nutricia, Fresenius Kabi AG, GlaxoSmithKline plc, Kate Farms, Inc., Mead Johnson & Company, LLC, Medifood GmbH, Medtrition Inc., Meiji Holdings Co., Ltd., Nestlé S.A., NUTRICIÓN MÉDICA SL, Otsuka Pharmaceutical Europe Ltd., Perrigo Company plc, Pfizer Inc., Sichuan Kelun Pharmaceutical Co., Ltd., and Victus, Inc.